Alnylam Pharmaceuticals, Inc $(ALNY)$ is currently at $358.27, down $0.99 or 0.28%

--Would be lowest close since July 30, 2025, when it closed at $339.80

--On pace for largest percent decrease since Jan. 15, 2026, when it fell 2.07%

--Currently down seven consecutive days; down 15.2% over this period

--Longest losing streak since Feb. 18, 2025, when it fell for seven straight trading days

--Worst seven-day stretch since the seven days ending Dec. 15, 2025, when it fell 15.87%

--Down 10.05% this week; worst weekly performance since the week ending Dec. 12, 2025, when it fell 13.22%

--Down 9.9% month-to-date

--Down 9.9% year-to-date

--Down 27.07% from its all-time closing high of $491.22 on Oct. 20, 2025

--Up 45.48% from 52 weeks ago (Jan. 17, 2025), when it closed at $246.27

--Down 27.07% from its 52-week closing high of $491.22 on Oct. 20, 2025

--Up 59.71% from its 52-week closing low of $224.32 on April 8, 2025

--Traded as low as $355.46

--Down 1.06% at today's intraday low

--Seventh least active stock in the Nasdaq 100 today

All data as of 2:19:36 PM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

January 16, 2026 14:23 ET (19:23 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.